PHARMEDIC PHARMACEUTICAL MEDICINAL |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 81,000 VND | +1.25% |
|
+1.25% | -5.92% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 529,157 | 492,760 | 536,623 | 611,284 | 793,269 | 803,535 |
| Enterprise Value (EV) 1 | 359,217 | 323,035 | 310,097 | 339,723 | 499,715 | 541,282 |
| P/E ratio | 9.84 x | 9.07 x | 9.85 x | 12.9 x | 13 x | 13.2 x |
| Yield | - | - | - | 3.66% | 3.53% | 17.4% |
| Capitalization / Revenue | 1.16 x | 1.06 x | 1.16 x | 1.48 x | 1.68 x | 1.66 x |
| EV / Revenue | 0.79 x | 0.7 x | 0.67 x | 0.82 x | 1.06 x | 1.12 x |
| EV / EBITDA | 3.74 x | 3.34 x | 3.11 x | 3.94 x | 4.85 x | 5.63 x |
| EV / FCF | 7.49 x | 11.9 x | 3.09 x | 5.22 x | 13.3 x | 5.19 x |
| FCF Yield | 13.3% | 8.41% | 32.3% | 19.1% | 7.52% | 19.3% |
| Price to Book | 2.18 x | 1.48 x | 1.47 x | 1.57 x | 1.85 x | 2.34 x |
| Nbr of stocks (in thousands) | 9,333 | 9,333 | 9,333 | 9,333 | 9,333 | 9,333 |
| Reference price 2 | 56,700 | 52,800 | 57,500 | 65,500 | 85,000 | 86,100 |
| Announcement Date | 3/28/19 | 3/27/20 | 3/23/21 | 3/31/22 | 3/29/23 | 3/28/24 |
1VND in Million2VND
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 454,572 | 464,772 | 460,764 | 414,232 | 472,274 | 485,186 |
| EBITDA 1 | 96,052 | 96,780 | 99,772 | 86,313 | 103,081 | 96,124 |
| EBIT 1 | 84,986 | 85,823 | 85,687 | 72,580 | 90,768 | 84,408 |
| Operating Margin | 18.7% | 18.47% | 18.6% | 17.52% | 19.22% | 17.4% |
| Earnings before Tax (EBT) 1 | 92,560 | 93,457 | 93,700 | 81,284 | 104,480 | 104,602 |
| Net income 1 | 73,649 | 74,420 | 74,618 | 64,760 | 83,416 | 83,564 |
| Net margin | 16.2% | 16.01% | 16.19% | 15.63% | 17.66% | 17.22% |
| EPS 2 | 5,761 | 5,821 | 5,837 | 5,066 | 6,525 | 6,536 |
| Free Cash Flow 1 | 47,943 | 27,156 | 100,238 | 65,033 | 37,573 | 104,285 |
| FCF margin | 10.55% | 5.84% | 21.75% | 15.7% | 7.96% | 21.49% |
| FCF Conversion (EBITDA) | 49.91% | 28.06% | 100.47% | 75.35% | 36.45% | 108.49% |
| FCF Conversion (Net income) | 65.1% | 36.49% | 134.33% | 100.42% | 45.04% | 124.8% |
| Dividend per Share | - | - | - | 2,400 | 3,000 | 15,000 |
| Announcement Date | 3/28/19 | 3/27/20 | 3/23/21 | 3/31/22 | 3/29/23 | 3/28/24 |
1VND in Million2VND
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 169,940 | 169,724 | 226,526 | 271,560 | 293,554 | 262,252 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 47,943 | 27,156 | 100,238 | 65,033 | 37,573 | 104,285 |
| ROE (net income / shareholders' equity) | 25.9% | 23.5% | 21.4% | 17.2% | 20.4% | 21.7% |
| ROA (Net income/ Total Assets) | 15.5% | 14.5% | 13.2% | 10.3% | 12% | 11.5% |
| Assets 1 | 476,261 | 512,395 | 566,500 | 628,534 | 695,230 | 729,044 |
| Book Value Per Share 2 | 26,007 | 35,585 | 39,022 | 41,669 | 45,838 | 36,774 |
| Cash Flow per Share 2 | 18,209 | 18,186 | 12,325 | 3,153 | 4,013 | 1,420 |
| Capex 1 | 8,436 | 9,359 | 9,687 | 3,962 | 5,318 | 8,012 |
| Capex / Sales | 1.86% | 2.01% | 2.1% | 0.96% | 1.13% | 1.65% |
| Announcement Date | 3/28/19 | 3/27/20 | 3/23/21 | 3/31/22 | 3/29/23 | 3/28/24 |
1VND in Million2VND
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -5.92% | 29.35M | |
| +32.07% | 694B | |
| +29.39% | 593B | |
| -1.75% | 371B | |
| +19.95% | 331B | |
| +6.87% | 290B | |
| +14.25% | 239B | |
| -3.03% | 209B | |
| +10.02% | 209B | |
| +7.93% | 169B |
- Stock Market
- Equities
- PMC Stock
- Financials Pharmedic Pharmaceutical Medicinal
